|Title||PharmAbcine' PMC-403 is featured on Pharma Tech Outlook|
PharmAbcine is featured on Pharma Tech Outlook, a monthly magazine that highlights breakthroughs in drug delivery system, pharmaceutical infrastructure, and tools.
The recently released Drug Discovery APAC Edition includes an exclusive article on PMC-403 from PharmAbcine, a first-in-class antibody that binds to the human Tie2 receptor.
The article introduces PMC-403’s unique mode of action and potential indications in both non-ocular and ocular pathological vessel related diseases.
Click the link below for more details.